Nonsteroidal anti-inflammatory drugs (NSAIDs) and cyclooxygenase (COX)-2-specific inhibitors provide significant analgesic and opioid-sparing benefits. However, these analgesics are commonly avoided owing to concerns of potential adverse effects. The evidence for NSAID-related adverse effects is conflicting and of poor quality, and these analgesics are safer than what has been implied. Thus, it is imperative that NSAIDs or COX-2-specific inhibitors are administered routinely unless there are well-founded contraindications.
Keywords: acute kidney injury; analgesics; nonsteroidal anti-inflammatory drugs; perioperative pain; persistent postoperative opioid use.
Copyright © 2024 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.